320 related articles for article (PubMed ID: 27901049)
1. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK
Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049
[TBL] [Abstract][Full Text] [Related]
2. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
[TBL] [Abstract][Full Text] [Related]
3. ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells.
Wang N; Wang H; Chen J; Wang F; Wang S; Zhou Q; Ying J; Huang S; Wang P; Yuan F
Mol Med Rep; 2020 Sep; 22(3):2451-2459. PubMed ID: 32705192
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
Johnson TE; Vogel R; Rutledge SJ; Rodan G; Schmidt A
Endocrinology; 1999 Jul; 140(7):3245-54. PubMed ID: 10385421
[TBL] [Abstract][Full Text] [Related]
5. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.
Ma X; Zhang X; Jia Y; Zu S; Han S; Xiao D; Sun H; Wang Y
Int Orthop; 2013 Jul; 37(7):1399-404. PubMed ID: 23645083
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone suppresses osteogenesis of osteoblast
Pan JM; Wu LG; Cai JW; Wu LT; Liang M
J Recept Signal Transduct Res; 2019 Feb; 39(1):80-86. PubMed ID: 31210570
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
Hildebrandt S; Baschant U; Thiele S; Tuckermann J; Hofbauer LC; Rauner M
Sci Rep; 2018 Jun; 8(1):8711. PubMed ID: 29880826
[TBL] [Abstract][Full Text] [Related]
12. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p.
Kang H; Chen H; Huang P; Qi J; Qian N; Deng L; Guo L
Osteoporos Int; 2016 Apr; 27(4):1493-1505. PubMed ID: 26556739
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
Atmani H; Audrain C; Mercier L; Chappard D; Basle MF
J Cell Biochem; 2002; 85(3):640-50. PubMed ID: 11968004
[TBL] [Abstract][Full Text] [Related]
15. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
Li H; Li T; Fan J; Li T; Fan L; Wang S; Weng X; Han Q; Zhao RC
Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
[TBL] [Abstract][Full Text] [Related]
16. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells.
Hong D; Chen HX; Xue Y; Li DM; Wan XC; Ge R; Li JC
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):86-92. PubMed ID: 19460432
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells.
Koromila T; Baniwal SK; Song YS; Martin A; Xiong J; Frenkel B
J Cell Biochem; 2014 Jan; 115(1):27-33. PubMed ID: 23943595
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone regulation of cFos mRNA in osteoprogenitors.
Shur I; Socher R; Benayahu D
J Cell Physiol; 2005 Jan; 202(1):240-5. PubMed ID: 15389524
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of VK2 on glucocorticoid-treated MC3T3-E1 cells.
Zhang YL; Yin JH; Ding H; Zhang W; Zhang CQ; Gao YS
Int J Mol Med; 2017 Jan; 39(1):160-166. PubMed ID: 27909721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
